Tag: epigenetic regulation in cancer

In the relentless pursuit of groundbreaking cancer therapies, a novel twist in the complex battle against tumor immune evasion has ...

Peptidyl-arginine deiminase 2 (PAD2) has emerged as a pivotal enzyme driving the progression of pancreatic ductal adenocarcinoma (PDAC), one of ...

In the rapidly evolving landscape of cancer immunotherapy, recent groundbreaking research delves into an underexplored yet pivotal component of the ...

In a groundbreaking advancement in the fight against pancreatic cancer, researchers have illuminated a novel molecular pathway that could pave ...

A groundbreaking review published in the latest issue of Molecular Biomedicine illuminates a critical frontier in molecular biology: lysine lactylation ...

In a groundbreaking study published in BMC Cancer, researchers have unveiled compelling evidence positioning E2F transcription factor 2 (E2F2) as ...

In a groundbreaking study poised to shift paradigms in breast cancer therapy, researchers have uncovered a pivotal molecular mechanism driving ...

The intricate interplay between RNA-binding proteins (RBPs) and cancer biology has garnered significant attention in recent years, with the fragile ...

SETDB1 amplification in osteosarcoma presents a striking development in oncology research, showcasing the intricate relationship between genetic anomalies and cancer ...